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Purpose: Many kinds of substances are produced on vascular endothelial activation. The aim of this study is to confirm an 
increase in Endothelin-1 (ET-1), the most potent vasoconstrictor, which is produced by endothelial activation, in patients 
with chronic anal fissure and to infer the relationship between ET-1 and anal fissure chronicity.
Methods: The study groups are divided into three different groups with 30 subjects each. Group 1 is comprised of healthy 
volunteers, group 2 of chronic anal fissure patients, and Group 3 of patients with higher than 3rd degree hemorrhoids. Blood 
samples were taken to measure the ET-1 levels in subject’s serum and to compare the results with those for the control groups.
Results: Among the 90 subjects, 38 were male, and 52 were female. The average age was 36.8. The average ET-1 level marked 
1.47 ± 0.78 pg/mL for male subjects and 1.16 ± 0.47 pg/mL for female subjects (P = 0.02). The average ET-1 level in the pa-
tient groups is as follow: 1.21 ± 0.44 pg/mL in group 1, 1.46 ± 0.83 pg/mL in group 2, and 1.20 ± 0.56 pg/mL in group 3 (P = 
0.14).
Conclusion: Group 2, the chronic anal fissure patient group, showed a higher ET-1 level than groups 1 and 3, the control 
group and the hemorrhoid patient group, but this difference had no statistical significance.
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inert barrier between the blood stream and vascular smooth mus-
cle; however, several studies showed that [3, 4] it is now known to 
be a functionally active structure. The cells that line blood vessels, 
through numerous stimuli, generate and release numerous sub-
stances [4, 5], among which Endothelin-1 (ET-1) is known to be 
the strongest vasoconstrictor and long-reactive substance [4]. ET-1 
is generated the most in the endothelium of blood vessels through 
infection, hypoxia, or physical strength [5]. As the generation of 
ET-1 increases, arteriosclerotic changes and fiberization increase; 
due to the increase in the ET-1 concentration within a cell, nitric-
oxide production is inhibited in the endothelium of blood vessels, 
eventually vasodilatation is inhibited [4, 5].
The authors made one hypothesis. The generation of ET-1 is in-
creased though activation of the endothelium of a blood vessel 
due to damage in the anal canal in a chronic anal fissure patient 
even though ET-1 may not be a direct cause of the anal fissure. 
Based on that hypothesis, this study attempted to investigate the 
chronicity of anal fissure and its association with ET-1 by quanti-
tatively measuring ET-1 in the serum of chronic anal fissure pa-
tients and comparing the results with those of the control group 
under the assumption that there is an association with the chro-
nicity of anal fissure.
INTRODUCTION
Anal fissure refers to a state of laceration in the direction of the-
longitudinal axis for the lower anal canal, which spans from the 
anal verge to the dentate line. Acute anal fissure can be treated in 
1-2 weeks, but chronic anal fissure can last 6-8 weeks and can re-
cur often [1]. Although the pathogenesis of chronic anal fissure is 
not yet certain, as speculative theoretical causes, extreme tension 
in the internal sphincter, myositis, ischemia, primary disorder of 
the internal sphincter, and the activation of vascular endothelium 
can be included [2].
In the past, the vascular endothelium was recognized as simply an 
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METHODS
Study subjects were divided into three groups: group 1, healthy 
adult volunteers without a history of anal diseases; group 2, pa-
tients with confirmed cases, through anal speculum, of chronic 
anal fissure among outpatients [1]; group 3, patients with hemor-
rhoids of Goligher classification 3 or higher and no other anal con-
ditions such as anal fissure or anal fistula; each group had 30 pa-
tients. In each group, patients with personal or family history of 
high blood pressure, cardiovascular disease, obesity (defined as 
being 10% over ideal body weight), smoking, diabetes, hyperlip-
idemia, arthritis, autoimmune disease, systemic inflammatory dis-
ease, inflammatory bowel disease, functional abnormality of the 
liver or liver disease, trauma or surgery within the prior 3-months, 
having received a blood transfusion, or malignant tumors were 
excluded because such factors could affect ET-1 levels [2].
Blood was collected (5 mL) from the forearm by using serum 
separation tubes (SST), was allowed to stand for 30 minutes at 
room temperature, and afterwards was centrifuged for 15 minutes 
at 1,000 G. The resulting serum was separated with SSTs, and the 
experiment proceeded. No hemolyzed serum or lipemic serum 
was used. The QuantiGlo
® Human ET-1 immunoassay kit (R & D 
System, Minneapolis, MN, USA) was used for quantitative analy-
sis of ET-1. Contained in the kit were an ET-1 microplate, an ET-1 
conjugate, an ET-1 standard, an assay diluent RD1-19, a calibrator 
diluent RD5-13, a wash buffer concentrate, Glo Reagent A, Glo 
Reagent B, and a plate cover. Preparatory steps taken for the ex-
periment included the following: First, 100 mL of the wash buffer 
concentrate contained in the reagents was diluted 10-fold by us-
ing distilled water (Type-1), and was prepared with a final volume 
of 1,000 mL. Second, 4 mL of Glo Reagent A and 8 mL of Glo Re-
agent B were prepared 15 minutes before use and were then set 
aside and stabilized. They were stored, using the reagents prepared 
4 hours before, in a darkroom (temperature, 18-24°C). Since 100 
μL of Glo Reagent is needed per the standard and the sample quan-
tities, its quantity was adjusted according to the number of tests. 
Third, 1.0 mL of distilled water was added to the standard (2.5 ng) 
by using a vortex, and it needed to be stabilized for at least 15 min-
utes. Fourth, 900 μL of the calibrator diluent RD5-13 was moved 
to a tube labeled 250 pg/mL by using a pipette, the prepared stan-
dard was moved into a 2,500 pg/mL labeled tube, and 100 μL was 
transferred into a 250 pg/mL labeled tube by using a pipette. Then, 
they were mixed well using a vortex. Into each of the remaining 
labeled tubes, 600 μL of calibrator diluent RD5-13 was divided, 
and from a 250-pg/mL standard, 300 μL with a pipette 250, 83.3, 
27.8, 9.26, 3.09, 1.03, 0.34 pg/mL was prepared using a step dilu-
tion method and set aside. As shown in the Fig. 1, a dilute solu-
tion for the standards is created. The solution in each tube must 
be mixed completely and the pipettes must not be reused.
Once all the preparatory steps had been completed, all reagents, 
serum samples, and standards were prepared at room temperature, 
and the following experimental steps were conducted: 1) prepare 
reagents, samples, and standards; 2) add 100 μL of assay diluents 
to each well; 3) add 100 μL of standard, control or sample to each 
well and incubate 1.5 hours on the shaker at room temperature; 4) 
aspirate and wash 4 times; 5) add 200 μL of conjugate to each well, 
incubate 3 hours on the shaker at room temperature, and prepare 
working Glo Reagent; 6) aspirate and wash 4 times; 7) add 100 μL 
of working reagent to each well and incubate for 5-20 minutes on 
the bench-top while protecting from light; 8) determine the RLU 
of each well by using a luminometer (DML 2000
®, Hoil Biomed, 
Seoul, Korea). By noting the measured values, we compared the 
patients in the anal fissure group with the patients in the control 
group to see if differences in the measured values of ET-1 existed. 
Statistical analyses were conducted using the SPSS ver. 12.0 (SPSS 
Inc., Chicago, IL, USA), and for continuous variables, the Student’s 
t-test was used for comparative analyses. Statistical significance 
was defined as P < 0.05 at the 95% confidence level.
RESULTS
Among the total 90 patients, there were 38 males and 52 females, 
and their average age was 36.8 years (Table 1). The results of the 
experiment showed ET-1 levels of 1.21 ± 0.44 pg/mL (range, 0.66 
to 2.25 pg/mL) for group 1, 1.46 ± 0.83 pg/mL (range, 0.6 to 3.69 
pg/mL) for Group 2, 1.20 ± 0.56 pg/mL (range, 0.58 to 2.68 pg/mL) 
(P = 0.14).
DISCUSSION
Anal fissure is one of the most frequently-occurring anal diseases. 
Acute anal fissure has a tendency to be cured within 1-2 weeks; 
Table 1. Characteristics of patients and the results of Endothelin-1 
(ET-1) for each group
Control Fissure Hemorrhoids
M/F 13/17 14/16 11/19
Age (yr) 33.73 ± 13.40 33.37 ± 13.19 43.30 ± 10.46
(20-57) (16-63) (22-61)
ET-1 (pg/mL) 1.21 ± 0.44 1.46 ± 0.83 1.20 ± 0.56 P = 0.14
Values are presented as mean ± standard deviation (range). Fig. 1. Method for making standard diluent solutions.
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however, chronic anal fissure can last a long time, and it can recur. 
Chronic anal fissure is generally defined as a fissure having a his-
tory of more than 6-8 weeks, not responding to conservative ther-
apy, having an ulcer base with fibers of the internal sphincter ex-
posed, and displaying one of these three abnormalities: indurated 
edge, thickened papilla above and below the ulcer, or sentinel pile 
[1]. In this study, as well, the above criteria were used for selecting 
chronic anal fissure patients.
Due to the infectious process of the anal tissues, collagenolytic 
enzymes are produced, which reduces the tensile strength of anal 
tissue and makes the tissue susceptible to damage from even a small 
stimulus [6]. Therefore, when a hard stool passes through an anal 
canal that is infected, this can cause damage to the anal skin. In 
these patients, the pressure in the internal anal sphincter generally 
appears elevated. However, it is not clear as to whether the elevated 
pressure is the cause of the anal fissure or the result of the anal fis-
sure. If the pressure in the internal anal sphincter continues to rise, 
this reduces the blood flow to this region and can cause chronicity 
of the anal fissure [2]. However, even without a rise of anal pressure, 
sometimes an anal fissure can occur and can heal naturally [7].
According to studies, an anal fissure can occur due to a localized 
ischemic process [8]. As in other organs, ischemic damage refers 
to the production of activated substances resulting from damage to 
the endothelium of a blood vessel [4]. The endothelium of a blood 
vessel is a confluent monolayer of thin, flattened, rhomboid-shaped 
cells lining the intimal surface of all blood vessels. It not only acts 
simply as a passive barrier to transvascular diffusion by being lo-
cated between the blood flow and tissues but also plays the role of 
the largest endocrine organ in the body [3, 4]. Normal endothelial 
cells serve to maintain the balance between growth promotion and 
inhibition, vasoconstriction and vasodilation, blood cell adherence 
and non-adherence, and anticoagulation and pro-coagulation [4]. 
The environmental effects that stimulate endothelial cells are bac-
terial or viral infections, hypoxia, physical force (shear stress), in-
creased blood pressure applied to all layers of the blood vessel, 
smoking and hyperlipidemia [5]. Endothelial cells, by detecting 
these physical, chemical, humoral or environmental stimuli, trans-
form blood vessels due to the pathological changes in the structure 
or function; the endothelial cells also play a critical role in main-
taining homeostasis by generating and secreting various activated 
substances [4]. Among these substances, ET-1, first discovered by 
Yanagisawa et al. [9] in 1988, is a 21-amino-acid peptide and serves 
as a very strong, long-lasting vasoconstrictor. There are three iso-
forms, ET-1, ET-2, and ET-3, in the endothelin family; ET-1 is the 
major form and it, through the receptors (ETA) in the vascular 
smooth muscle, functions locally or systemically in a paracrine or 
an autocrine form [3, 4, 9, 10]. Thus, it induces abnormal manifes-
tations, such as vasoconstriction, vascular spasms, vascular hyper-
trophy, etc. [5]; although with limited data, evidence exists that 
ET-1 plays some role in the clinical manifestation of vasculitis [11]. 
If ET-1 is generated due to damage in or activation of the endo-
thelium of a blood vessel, then suppression of endothelial nitric-
oxide generation, hyperactive production of fibrous tissues, acti-
vation of chemotaxis of leukocytes and inflammation due to cyto-
kines such as interleukin-6 can be induced [4].
Under the assumption that the chronicity of an anal fissure can 
persist due to changes causing the anal pressure to elevate and caus-
ing ischemia to accelerate, this study was conducted. In the selec-
tion of subject patients, patients with various cardiovascular dis-
ease conditions [2] that could raise the level of ET-1 were excluded. 
One group consisted of normal patients without anal diseases such 
as anal fissure, hemorrhoids, etc. A second group consisted of anal 
fissure patients who met the chronic anal fissure condition [1], and 
a third group consisted of hemorrhoid patients who were over 3rd 
degree in the Goligher classification. The ET-1 levels in the serum 
of the patients in these groups were compared and analyzed. Al-
though the normal group and the group of anal fissure patients did 
not show any difference in terms of the age distribution, the group 
of hemorrhoid patients showed a difference in age compared to 
the other groups because that group included only patients with 
over a 3rd degree Goligher classification. However, this difference 
in age did not affect the ET-1 levels. The average ET-1 levels were 
1.21 pg/mL for the normal group, 1.46 pg/mL for the group of anal 
fissure patients and 1.20 pg/mL for the group of hemorrhoid pa-
tients. Although the group of anal fissure patients showed higher 
ET-1 levels than the other groups, there was no statistical signifi-
cance (P = 0.14). Currently, in terms of the authors’ hypothesis, 
the experimental results from the beginning stage of this study 
have not shown statistically significant levels of association between 
ET-1 and chronicity of anal fissure; however, statistical analyses of 
further studies with a greater number of subject patients is deemed 
to be necessary. In addition, whether ET-1 can be a cause for anal 
fissure, whether ET-1 can be a causal factor that perpetuates the 
chronicity of anal fissure, or, if it is indeed a causal factor, whether 
inhibiting the generation of ET-1 or blocking its receptors (ETA) 
[4, 10] will enable treatment of chronic anal fissure are points of 
interest that warrant additional study in the future.
Although the serum ET-1 levels of the chronic anal fissure patient 
group appear elevated compared to those of the normal group or 
the hemorrhoid patient group, this difference has no statistical sig-
nificance. However, continuing studies in the future to establish 
whether an association exists between ET-1 and the chronicity of 
anal fissure are deemed to be necessary.
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